Nanotechnologies - 5-(and 6)-Chloromethyl-2’,7’ Dichlorodihydrofluorescein diacetate (CMH2DCF- DA) assay for evaluating nanoparticle-induced intracellular reactive oxygen species (ROS) production in RAW 264.7 macrophage cell line
Introduction: The field of nanotechnology continues to advance rapidly through the development of new materials, products and applications. At the same time, many questions have been raised relating to the potential impact on human health and on the environment of some of these materials. Internationally, a large programme of research is underway to better understand and quantify potential hazards. Also, the chemicals used to coat the surface of nanoparticles in processing or in products can affect the interactions of nanoparticles with cells, even more so due to their large surface to volume ratio. Thus, there is a need for reliable fast screening methods to determine the potential toxicity aspects of nanoparticles with characterization of chemical functionalization on nanoparticles. It is likely that monitoring biological response of cellular model systems to nanoparticle exposure can provide insight into the “modes-of-action” of nanoparticles and which of them may need to be further investigated for risk assessment. In 2008, a number of international researchers concluded that some published results of nanomaterial toxicity could not be replicated across laboratories and that accurate and reproducible nanotoxicology tests were needed. As a result of this, the International Alliance for NanoEHS Harmonization (IANH) was formed with the goal of developing testing protocols that would accurately assess toxicity and biological interactions of nanoparticles in cellular systems and that these
Scope: This document describes how to test and evaluate results obtained from in vitro ROS generation in RAW 264.7 macrophage cells exposed to nano-objects, nanoparticles, their aggregates and agglomerates using the CM-H2DCFDA assay. The protocol in this document is limited to use of a 24 well plate so if other plates were to be used, volumes would need to be adjusted and the protocol steps validated to ensure confidence in the test results.